The Centre aims to channel the potential of traditional medicine by integrating it with technological advancements and evidence-based research
Through the contract, the company will supply two key GMP intermediates for one of the 'patented drugs' of the innovator pharmaceutical customer
Parkinson’s is not limited to old people, even youngsters can suffer from this disease
Ocular hypertension affects over 5% of all adults; the eye does not properly drain fluid, causing eye pressure to build up
An RMAT confers eligibility for accelerated approval and priority review of biologics licensing applications (BLA)
Shoreline has developed a proprietary methodology to create differentiated iNK cells for large-scale, "off-the-shelf" production
The peptide-based vaccine induces a t cell-dependent response
This could be a game-changer for the prevention of the disease; seeing more doses of the life-saving jab reach more girls
Pharmapack trends are a key barometer of global device and packing opportunities in 2022
GRC 54276 has shown tumour cell killing ability in preclinical studies as a single agent and as well in combination with checkpoint inhibitors, making it a high-priority target in immuno-oncology
Subscribe To Our Newsletter & Stay Updated
